MX1 and myeloid sarcoma: In the time-course expression data by Karlovich et al. [50], we observed that approximately one-fifth of the healthy subjects showed relatively elevated MX1 transcript levels in the blood, which is very similar to the proportion we ascertained for the MS patients in our study.